These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16952176)

  • 1. Development and validation of a model predicting graft survival after liver transplantation.
    Ioannou GN
    Liver Transpl; 2006 Nov; 12(11):1594-606. PubMed ID: 16952176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation in the United States: a report from the UNOS Liver Transplant Registry.
    Smith CM; Davies DB; McBride MA
    Clin Transpl; 1999; ():23-34. PubMed ID: 11038623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function.
    Desai NM; Mange KC; Crawford MD; Abt PL; Frank AM; Markmann JW; Velidedeoglu E; Chapman WC; Markmann JF
    Transplantation; 2004 Jan; 77(1):99-106. PubMed ID: 14724442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States.
    Russo MW; Galanko J; Beavers K; Fried MW; Shrestha R
    Liver Transpl; 2004 Mar; 10(3):340-6. PubMed ID: 15004758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors.
    Aloia TA; Knight R; Gaber AO; Ghobrial RM; Goss JA
    Liver Transpl; 2010 Aug; 16(8):950-9. PubMed ID: 20589647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
    Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
    Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation.
    Moore DE; Feurer ID; Speroff T; Gorden DL; Wright JK; Chari RS; Pinson CW
    Arch Surg; 2005 Mar; 140(3):273-7. PubMed ID: 15781792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting graft survival after liver transplantation from donation after cardiac death donors.
    Lee KW; Simpkins CE; Montgomery RA; Locke JE; Segev DL; Maley WR
    Transplantation; 2006 Dec; 82(12):1683-8. PubMed ID: 17198260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MELD and prediction of post-liver transplantation survival.
    Habib S; Berk B; Chang CC; Demetris AJ; Fontes P; Dvorchik I; Eghtesad B; Marcos A; Shakil AO
    Liver Transpl; 2006 Mar; 12(3):440-7. PubMed ID: 16498643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient?
    Maluf DG; Edwards EB; Kauffman HM
    Transplantation; 2006 Dec; 82(12):1653-7. PubMed ID: 17198254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost prediction in liver transplantation using pretransplant donor and recipient characteristics.
    Earl TM; Cooil B; Rubin JE; Chari RS
    Transplantation; 2008 Jul; 86(2):238-44. PubMed ID: 18645485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
    Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
    Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era.
    Weiss ES; Allen JG; Patel ND; Russell SD; Baumgartner WA; Shah AS; Conte JV
    Circ Heart Fail; 2009 Sep; 2(5):401-8. PubMed ID: 19808369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
    Yu L; Koepsell T; Manhart L; Ioannou G
    Liver Transpl; 2009 Oct; 15(10):1343-50. PubMed ID: 19790164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study.
    Angelico M; Nardi A; Romagnoli R; Marianelli T; Corradini SG; Tandoi F; Gavrila C; Salizzoni M; Pinna AD; Cillo U; Gridelli B; De Carlis LG; Colledan M; Gerunda GE; Costa AN; Strazzabosco M;
    Dig Liver Dis; 2014 Apr; 46(4):340-7. PubMed ID: 24411484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
    Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation.
    Selzner M; Kashfi A; Selzner N; McCluskey S; Greig PD; Cattral MS; Levy GA; Lilly L; Renner EL; Therapondos G; Adcock LE; Grant DR; McGilvray ID
    Liver Transpl; 2009 Oct; 15(10):1288-95. PubMed ID: 19790152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.